...
首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Development of an assay to simultaneously measure orotic acid, amino acids, and acylcarnitines in dried blood spots
【24h】

Development of an assay to simultaneously measure orotic acid, amino acids, and acylcarnitines in dried blood spots

机译:同时测定干血斑中的乳清酸,氨基酸和酰基肉碱的测定方法的开发

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Orotic aciduria in the presence of hyperammonemia is a key indicator for a defect in the urea cycle, specifically ornithine transcarbamylase (OTC) deficiency. Current newborn screening (NBS) protocols can detect several defects of the urea cycle, but screening for OTC deficiency remains a challenge due to the lack of a suitable assay. The purpose of this study was to develop a high-throughput assay to measure orotic acid in dried blood spot (DBS) specimens as an indicator for urea cycle dysfunction, which can be readily incorporated into routine NBS.Methods: Orotic acid was extracted from DBS punches and analyzed using flow-injection analysis tandem mass spectrometry (F1A-MS/MS) with negative-mode ionization, requiring <2 min/sample run time. This method was then multiplexed into a conventional newborn screening assay for analysis of amino acids, acylcarnitines, and orotic acid.Results: We describe 2 assays which can quantify orotic acid in DBS: a stand-alone method and a combined method for analysis of orotic acid, amino acids, and acylcarnitines. Both methods demonstrated orotic acid recovery of 75-85% at multiple levels of enrichment. Precision was also comparable to traditional FIA-MS/MS methods. Analysis of residual presumptively normal NBS specimens demonstrated a 5:1 signal to noise ratio and the average concentration of orotic acid was approximately 1.2 umol/l. The concentration of amino acids and acylcarnitines as measured by the combined method showed no significant differences when compared to the conventional newborn screening assay. In addition, retrospective analysis of confirmed patients and presumptively normal newborn screening specimens suggests potential for the methods to identify patients with OTC deficiency, as well as other urea cycle defects.Conclusion: The assays described here quantify orotic acid in DBS using a simple extraction and FIA-MS/MS analysis procedures that can be implemented into current NBS protocols.
机译:背景:高氨血症时的尿酸是尿素循环缺陷的关键指标,尤其是鸟氨酸转氨甲酰酶(OTC)缺乏。当前的新生儿筛查(NBS)方案可以检测尿素循环的几个缺陷,但是由于缺乏合适的测定方法,因此OTC缺乏症筛查仍然是一个挑战。这项研究的目的是开发一种高通量测定方法来测量干血斑(DBS)标本中的乳清酸,作为尿素循环功能障碍的指标,可以很容易地将其纳入常规NBS中。使用负离子模式电离的流动注射分析串联质谱(F1A-MS / MS)分析和分析,每运行时间少于2分钟。然后将该方法复用到常规的新生儿筛查测定法中,以分析氨基酸,酰基肉碱和乳清酸。结果:我们描述了两种可以定量DBS中乳清酸的测定法:一种独立方法和一种组合的方法来分析乳清液酸,氨基酸和酰基肉碱。两种方法均表明在多个富集水平下乳清酸的回收率为75-85%。精度也可以与传统的FIA-MS / MS方法媲美。对残留的假定为正常的NBS标本的分析表明信噪比为5:1,乳清酸的平均浓度约为1.2 umol / l。与常规新生儿筛查分析相比,通过联合方法测得的氨基酸和酰基肉碱浓度没有显着差异。此外,对确诊患者和推定正常的新生儿筛查标本进行的回顾性分析表明,这种方法有可能用于识别OTC缺乏症以及其他尿素循环缺陷的患者。结论:本文所述的测定方法通过简单的提取和定量分析DBS中的乳清酸。可以在当前NBS协议中实施的FIA-MS / MS分析程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号